Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
ChAdOx1 nCoV-19 Potential treatment - clinical evidence Experimental Vaccine Nov/18/2020 Nov/24/2020 0
Remdesivir Approved by FDA Experimental Antiviral Nov/12/2020 Nov/24/2020 0
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/10/2020 Nov/24/2020 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Nov/09/2020 Nov/24/2020 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Nov/09/2020 Nov/24/2020 0
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/08/2020 Nov/24/2020 0
Convalescent plasma Emergency use authorization Used to treat other disease Other treatment Nov/05/2020 Nov/24/2020 0
Bemcentinib Potential treatment - pre-clinical evidence Experimental Antiviral Nov/05/2020 Nov/24/2020 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Oct/20/2020 Nov/24/2020 0
Cyclosporine Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/15/2020 Nov/24/2020 0